Home » Menarini: 4.15 billion turnover in 2022, +6% on 2021 – Healthcare

Menarini: 4.15 billion turnover in 2022, +6% on 2021 – Healthcare

by admin

In 2022, the Menarini group achieved a turnover of 4.154 billion euros, with a growth of 6% compared to 2021, and an Ebitda of approximately 400 million. This is what the top management of the pharmaceutical group communicated today in Florence during a press event.
22% of the group’s consolidated turnover is achieved in Italy and 78% internationally: 94% comes from the pharmaceutical sector, and 5% from diagnostics.
Menarini’s 2022 results make it the 17th player in the European sector ranking, and the 32nd worldwide. The group employs a total of 17,800, of which 49.5% are women: 762 million packs produced, of which 553 produced internally, exceeding 1 billion blisters.

breaking latest news © Copyright ANSA


This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy